Given that AMBS owns about 40% of Avant, does anyone have any updates on development/utilization of OvaDx, MSPrecise, LymPro, or Theralink? If just one of these diagnostics becomes a mainstream diagnostic tool covered by insurance it would be huge for AMBS.